Inventera Inc. (KOSDAQ:0007J0)
South Korea
· Delayed Price · Currency is KRW 22,900
0.00 (0.00%)
At close: Apr 29, 2026
Inventera Company Description
Inventera Inc. operates as a biotechnology company specializing in the development of MRI contrast agents.
The company offers nanoparticle-based platforms, designed to enhance both the resolution and safety of MRI.
The company develops contrast agents targeting the articular system, lymphatic vessels, and the pancreatic and biliary systems.
Inventera Inc. was incorporated in 2018 and is based in Seoul, South Korea.
Inventera Inc.
| Country | South Korea |
| Founded | 2018 |
| Industry | In Vitro and In Vivo Diagnostic Substances |
| CEO | Tae-Hyun Shin |
Contact Details
Address: 2F Seoul, 06588 South Korea | |
| Phone | 82 2 533 1102 |
| Website | inventera.kr |
Stock Details
| Ticker Symbol | 0007J0 |
| Exchange | KOSDAQ |
| Reporting Currency | KRW |
| SIC Code | 2835 |
Key Executives
| Name | Position |
|---|---|
| Tae-Hyun Shin | Chief Executive Officer |